BioXcel Therapeutics (BTAI) Other Gross PP&E Adjustments (2022 - 2025)
Historic Other Gross PP&E Adjustments for BioXcel Therapeutics (BTAI) over the last 4 years, with Q3 2025 value amounting to $712000.0.
- BioXcel Therapeutics' Other Gross PP&E Adjustments rose 11778.22% to $712000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $712000.0, marking a year-over-year increase of 11778.22%. This contributed to the annual value of -$9000.0 for FY2024, which is 9978.94% up from last year.
- According to the latest figures from Q3 2025, BioXcel Therapeutics' Other Gross PP&E Adjustments is $712000.0, which was up 11778.22% from $250000.0 recorded in Q2 2025.
- In the past 5 years, BioXcel Therapeutics' Other Gross PP&E Adjustments registered a high of $712000.0 during Q3 2025, and its lowest value of -$7.3 million during Q3 2023.
- Moreover, its 4-year median value for Other Gross PP&E Adjustments was -$2.7 million (2023), whereas its average is -$2.5 million.
- Its Other Gross PP&E Adjustments has fluctuated over the past 5 years, first plummeted by 80308.64% in 2023, then surged by 11778.22% in 2025.
- Over the past 4 years, BioXcel Therapeutics' Other Gross PP&E Adjustments (Quarter) stood at -$1.7 million in 2022, then plummeted by 144.87% to -$4.3 million in 2023, then surged by 99.79% to -$9000.0 in 2024, then skyrocketed by 8011.11% to $712000.0 in 2025.
- Its Other Gross PP&E Adjustments was $712000.0 in Q3 2025, compared to $250000.0 in Q2 2025 and $336000.0 in Q1 2025.